サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1464918

コルヒチン市場：剤形、年齢、投与経路、販売チャネル、用途別-世界予測2024-2030年

Colchicine Market by Dosage Formulation (Liquid, Semisolid Gel, Solid), Age (Adult, Children, Senior), Route of Administration, Sales Channels, Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
コルヒチン市場：剤形、年齢、投与経路、販売チャネル、用途別-世界予測2024-2030年
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コルヒチン市場規模は2023年に14億6,000万米ドルと推計され、2024年には15億8,000万米ドルに達し、CAGR 7.85%で2030年には24億9,000万米ドルに達すると予測されています。

コルヒチンは、一般にオータムクロッカスとして知られる植物Colchicum autumnaleから得られる薬です。痛風発作や心膜炎への有効性から、医療において重要な位置を占めています。コルヒチンの使用が拡大している主な理由は、これらの症状に関連する炎症を効果的に管理・軽減し、患者のQOLを向上させる可能性があるためです。さらに、コルヒチンの用途は心血管系疾患の管理にも広がっており、従来の用途を超えた可能性を示しています。その利点にもかかわらず、コルヒチンの使用は、その狭い治療指数によって妨げられており、適切に投与されなければ潜在的な毒性につながります。この制約を緩和するには、厳格な投与ガイドラインを遵守し、安全性と有効性を確保するためにヘルスケア専門家がモニタリングする必要があります。抗炎症メカニズムを探求する継続的な研究により、新たな治療適応がもたらされる可能性があり、ヘルスケア分野での応用範囲が広がります。

主な市場の統計
基準年[2023］ 14億6,000万米ドル
予測年［2024] 15億8,000万米ドル
予測年 [2030] 24億9,000万米ドル
CAGR（%） 7.85%

剤形：コルヒチン錠剤の使いやすさ、安定性、普及性

コルヒチンの液剤は、特に錠剤や錠剤を飲み込むことが困難な患者にとって、投与のしやすさという点で利点があります。また、投与量の柔軟性があり、必要に応じて投与量を調整することが容易です。液体製剤は、特に小児および老人患者に有益です。半固形ゲル製剤は、コルヒチンを局所投与するための別の投与経路を提供します。この製剤は局所治療に適しており、経口コルヒチンに伴う全身的副作用を最小限に抑えることができます。錠剤とカプセルを含む固形製剤は、コルヒチンの最も伝統的で広く使用されている製剤です。正確な投与、安定性、保管や輸送の利便性などの利点があります。

応用例痛風治療におけるコルヒチンの有効性と安全性の向上

光線性角化症は、主に長期間の日光曝露によって引き起こされる、皮膚のざらざらしたうろこ状の斑点によって描かれる皮膚疾患です。従来は治療の第一選択ではありませんでしたが、患者が他の治療に耐えられない特定の症例に使用されることがあります。ベーチェット病は、全身の血管に炎症を起こすまれな疾患です。コルヒチンは、口内炎や性器潰瘍などの症状を抑えることができるため、支持されています。水疱ができる慢性の皮膚疾患である疱疹状皮膚炎では、標準的なダプソン療法に抵抗性がある場合の代替療法としてコルヒチンが使用されています。家族性地中海熱（FMF）は、再発性の発熱と炎症状態を引き起こす遺伝性疾患です。コルヒチンはFMFの主な治療法であり、アミロイドーシスを含む発作や合併症を予防します。痛風は、突然の激しい痛み、腫れ、発赤、圧痛を伴う関節炎の一種です。骨ページェット病は、骨組織の異常な破壊と形成を伴う。

地域的洞察

南北アメリカ、特に米国では、コルヒチンの使用は特許やFDAの承認によって厳しく規制されています。北米の大手製薬会社は継続的な研究開発に取り組んでおり、先進的だが高価なヘルスケアの枠組みを構築しています。インドや中国などのAPAC地域はコルヒチンの生産において極めて重要であり、その理由は大規模なジェネリック医薬品製造能力にあります。これらの国々は、世界の基準を満たす努力をしながら、費用対効果の高い生産に重点を置いており、世界中の市場に手頃な価格のコルヒチンを供給する上で重要な役割を果たしています。EMEA地域は、国によって規制環境が異なるため、多様なアプローチを示しています。欧州諸国は、南北アメリカと同様の厳しい規制基準を維持し、安全性と有効性を重視し、強力なジェネリック医薬品市場の存在感を示しています。中東・アフリカ市場は、経済格差の影響を受け、アクセスや購入しやすさに関する課題に直面しているもの、コルヒチンの重要性を認識しつつあります。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはコルヒチン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、コルヒチン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.コルヒチン市場の市場規模および予測は？

2.コルヒチン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.コルヒチン市場の技術動向と規制枠組みは？

4.コルヒチン市場における主要ベンダーの市場シェアは？

5.コルヒチン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 痛風と心血管疾患の罹患率が世界的に上昇
      • コルヒチンが他の炎症性疾患の治療に有効であることを示唆する新たな調査
      • 心血管疾患管理の必要性の高まり
    • 抑制要因
      • FDA承認メーカーの数が限られている
    • 機会
      • 徐放性製剤または併用療法の開発
      • 薬剤のバイオアベイラビリティの向上、副作用の軽減、患者のコンプライアンス強化に向けた研究開発への投資の増加
    • 課題
      • 患者の安全性と有効性を保証する規制状況
  • 市場セグメンテーション分析
    • 投与量処方：コルヒチン錠剤の使いやすさ、安定性、および幅広い入手可能性
    • 応用：痛風治療におけるコルヒチンの有効性と安全性の向上
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 コルヒチン市場投与量処方別

  • 液体
  • 半固体ゲル
  • 固体

第7章 コルヒチン市場年齢別

  • 成人用
  • 子供たち
  • シニア

第8章 コルヒチン市場：投与経路別

  • オーラル
  • 話題

第9章 コルヒチン市場販売チャネル別

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第10章 コルヒチン市場：用途別

  • 日光角化症
  • ベーチェット病
  • 疱疹状皮膚炎
  • 家族性地中海熱
  • 痛風
  • パジェット病

第11章 南北アメリカのコルヒチン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のコルヒチン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのコルヒチン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • エンド社、ミティガレのジェネリック版「コルヒチンカプセル」を発売
    • アゲファ・ファーマ、心臓病治療薬として古くからある痛風治療薬コルヒチンをFDA承認へ
  • 戦略分析と提言

第15章 競争力のあるポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. COLCHICINE MARKET RESEARCH PROCESS
  • FIGURE 2. COLCHICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COLCHICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLCHICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COLCHICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY SEMISOLID GEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY SEMISOLID GEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY SOLID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY SOLID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY ADULT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY ADULT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY CHILDREN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY SENIOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY SENIOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL COLCHICINE MARKET SIZE, BY ACTINIC KERATOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL COLCHICINE MARKET SIZE, BY ACTINIC KERATOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL COLCHICINE MARKET SIZE, BY BEHCET'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL COLCHICINE MARKET SIZE, BY BEHCET'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL COLCHICINE MARKET SIZE, BY DERMATITIS HERPETIFORMIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL COLCHICINE MARKET SIZE, BY DERMATITIS HERPETIFORMIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL COLCHICINE MARKET SIZE, BY PAGET'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL COLCHICINE MARKET SIZE, BY PAGET'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
目次
Product Code: MRR-351BAD503AE4

[197 Pages Report] The Colchicine Market size was estimated at USD 1.46 billion in 2023 and expected to reach USD 1.58 billion in 2024, at a CAGR 7.85% to reach USD 2.49 billion by 2030.

Colchicine is a medication derived from the plant Colchicum autumnale, commonly known as autumn crocus. It holds a significant place in medical treatment for its efficacy in addressing gout attacks and pericarditis. The expanding use of colchicine is primarily fueled by its potential to manage and reduce the inflammation associated with these conditions effectively, thereby improving patients' quality of life. Furthermore, its application is broadening in cardiovascular disease management, showcasing potential beyond traditional uses. Despite its benefits, colchicine's use is hindered by its narrow therapeutic index, leading to potential toxicity if not dosed properly. This restraint can be mitigated through adherence to strict dosing guidelines and monitoring by healthcare professionals to ensure safety and efficacy. Ongoing research exploring its anti-inflammatory mechanisms may introduce new therapeutic indications, expanding its applicability in the healthcare sector.

KEY MARKET STATISTICS
Base Year [2023] USD 1.46 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 7.85%

Dosage Formulation: Ease of use, stability, and widespread availability of colchicine tablets

The liquid formulation of colchicine offers advantages in terms of ease of administration, especially for patients who have difficulty swallowing pills or tablets. It allows for dose flexibility, making it easier to adjust doses as required. Liquid formulations are particularly beneficial for pediatric and geriatric patients. The semisolid gel formulation provides an alternative route of administration for colchicine, applied topically. This formulation is preferred for localized treatment, thus minimizing systemic side effects associated with oral colchicine. The solid formulation, encompassing tablets and capsules, is the most traditional and widely used form of colchicine. It offers the benefit of precise dosing, stability, and convenience in terms of storage and transportation.

Application: Improved efficacy and safety of colchicine in gout treatments

Actinic keratosis is a skin condition portrayed by rough, scaly patches on the skin, primarily caused by long-term exposure to the sun. While traditionally not the first line of treatment, colchicine can be used in specific cases where patients cannot tolerate other treatments. Behcet's disease is a rare disorder causing blood vessel inflammation throughout the body. Colchicine is favored for its ability to reduce symptoms such as mouth sores and genital ulcers. Dermatitis herpetiformis, a chronic skin condition that causes blisters, has seen colchicine used as an alternative treatment when patients are resistant to the standard dapsone therapy. Familial mediterranean fever (FMF) is a genetic disorder that causes recurrent fevers and inflammatory conditions. Colchicine is the primary treatment for FMF, preventing attacks and complication, including amyloidosis. Gout is a form of arthritis symptomed sudden, severe episodes of pain, swelling, redness, and tenderness. Paget's disease of bone involves the abnormal breakdown and formation of bone tissue.

Regional Insights

In the Americas, particularly in the United States, colchicine's use is strictly regulated with patents and FDA approval governing its prescription, a scenario that underscores the region's focus on quality and compliance. The major pharmaceutical companies in North America engage in continuous research and development, leading to an advanced but expensive healthcare framework. The APAC region, with countries such as India and China, is pivotal in the production of Colchicine, which is attributed to their large-scale generic pharmaceutical manufacturing capabilities. These countries focus on cost-effective production while striving to meet global standards, playing a crucial role in supplying affordable Colchicine to markets worldwide. The EMEA region showcases a diverse approach due to varying regulatory environments across countries. European nations maintain strict regulatory standards similar to those of the Americas, emphasizing safety and efficacy, coupled with a strong generic market presence. The Middle East and African markets are increasingly recognizing the importance of Colchicine, albeit facing challenges related to access and affordability, influenced by economic disparities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Colchicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Colchicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Colchicine Market, highlighting leading vendors and their innovative profiles. These include AGEPHA Pharma USA, LLC, Alchem International Pvt Ltd, Ascend Laboratories, LLC, Aurobindo Pharma Limited, Bio-Techne Corporation, bioWORLD by GeneLinx International, Inc., Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Endo International PLC, EURO-PHARM International Canada Inc., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Hikma Pharmaceuticals, Indena S.p.A., LGM Pharma, Odan Laboratories Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Vital Laboratories Private Limited.

Market Segmentation & Coverage

This research report categorizes the Colchicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Dosage Formulation
    • Liquid
    • Semisolid Gel
    • Solid
  • Age
    • Adult
    • Children
    • Senior
  • Route of Administration
    • Oral
    • Topical
  • Sales Channels
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Application
    • Actinic Keratosis
    • Behcet's Disease
    • Dermatitis Herpetiformis
    • Familial Mediterranean Fever
    • Gout
    • Paget's Disease
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Colchicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Colchicine Market?

3. What are the technology trends and regulatory frameworks in the Colchicine Market?

4. What is the market share of the leading vendors in the Colchicine Market?

5. Which modes and strategic moves are suitable for entering the Colchicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of gout and cardiovascular diseases globally
      • 5.1.1.2. Emerging research suggesting the potential of colchicine in treating other inflammatory diseases
      • 5.1.1.3. Growing need of cardiovascular disease management
    • 5.1.2. Restraints
      • 5.1.2.1. Limited number of FDA-approved manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing sustained-release formulations or combination therapies
      • 5.1.3.2. Rising investment in R&D to improving the drug's bioavailability, reducing its side effects, and enhancing patient compliance
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory landscape ensuring patient safety and efficacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Dosage Formulation: Ease of use, stability, and widespread availability of colchicine tablets
    • 5.2.2. Application: Improved efficacy and safety of colchicine in gout treatments
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Colchicine Market, by Dosage Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Semisolid Gel
  • 6.4. Solid

7. Colchicine Market, by Age

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Children
  • 7.4. Senior

8. Colchicine Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Topical

9. Colchicine Market, by Sales Channels

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Colchicine Market, by Application

  • 10.1. Introduction
  • 10.2. Actinic Keratosis
  • 10.3. Behcet's Disease
  • 10.4. Dermatitis Herpetiformis
  • 10.5. Familial Mediterranean Fever
  • 10.6. Gout
  • 10.7. Paget's Disease

11. Americas Colchicine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Colchicine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Colchicine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Endo Launches Colchicine Capsules, Generic Version of MITIGARE
    • 14.3.2. Agepha Pharma gets ancient gout remedy colchicine across the FDA finish line for heart disease
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio